pirenzepine has been researched along with Asthenia in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Asthenia: Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.
Excerpt | Relevance | Reference |
---|---|---|
" The purpose of this study was to assess the potential for pharmacokinetic interaction between olanzapine and fluoxetine, a popular antidepressant that is a selective serotonin reuptake inhibitor." | 2.70 | Influence of fluoxetine on olanzapine pharmacokinetics. ( de Suray, JM; Gangji, D; Gossen, D; Onkelinx, C; Vandenhende, F, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gossen, D | 1 |
de Suray, JM | 1 |
Vandenhende, F | 1 |
Onkelinx, C | 1 |
Gangji, D | 1 |
1 trial available for pirenzepine and Asthenia
Article | Year |
---|---|
Influence of fluoxetine on olanzapine pharmacokinetics.
Topics: Adult; Antipsychotic Agents; Asthenia; Benzodiazepines; Cross-Over Studies; Depressive Disorder; Dru | 2002 |